These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 20148895)
1. Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis. Li Y; Zhu X; Gu J; Dong D; Yao J; Lin C; Huang K; Fei J Cancer Sci; 2010 Apr; 101(4):948-54. PubMed ID: 20148895 [TBL] [Abstract][Full Text] [Related]
2. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188 [TBL] [Abstract][Full Text] [Related]
3. hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide. He JH; Li YM; Li YG; Xie XY; Wang L; Chun SY; Cheng WJ Exp Ther Med; 2013 May; 5(5):1315-1321. PubMed ID: 23737871 [TBL] [Abstract][Full Text] [Related]
4. Synergistic apoptosis induction in leukemic cells by miR-15a/16-1 and arsenic trioxide. Gao SM; Chen C; Wu J; Tan Y; Yu K; Xing CY; Ye A; Yin L; Jiang L Biochem Biophys Res Commun; 2010 Dec; 403(2):203-8. PubMed ID: 21056550 [TBL] [Abstract][Full Text] [Related]
5. [Study on the sensitivity of leukemic cells to arsenic trioxide enhanced by targeted suppression of mIRNA-21]. Li YM; Gu JY; Zhu XJ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):170-3. PubMed ID: 20462046 [TBL] [Abstract][Full Text] [Related]
6. Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis. Li Y; Zhu X; Gu J; Hu H; Dong D; Yao J; Lin C; Fei J Hematology; 2010 Aug; 15(4):215-21. PubMed ID: 20670480 [TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells. Hu H; Li Y; Gu J; Zhu X; Dong D; Yao J; Lin C; Fei J Leuk Lymphoma; 2010 Apr; 51(4):694-701. PubMed ID: 20141427 [TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum stress-mediated apoptosis in imatinib-resistant leukemic K562-r cells triggered by AMN107 combined with arsenic trioxide. Xia Y; Fang H; Zhang J; Du Y Exp Biol Med (Maywood); 2013 Aug; 238(8):932-42. PubMed ID: 23883479 [TBL] [Abstract][Full Text] [Related]
9. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution. Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330 [TBL] [Abstract][Full Text] [Related]
10. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia. Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050 [TBL] [Abstract][Full Text] [Related]
11. [Effect of Arsenic Trioxide on K562 Cell Proliferation and Its Mechanism]. Wang Y; Yang J; Li J; Wang RC; Yuan J; Li Y; Wang SY; Wang C; Hao HL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):90-93. PubMed ID: 28245381 [TBL] [Abstract][Full Text] [Related]
12. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L). Perkins C; Kim CN; Fang G; Bhalla KN Blood; 2000 Feb; 95(3):1014-22. PubMed ID: 10648417 [TBL] [Abstract][Full Text] [Related]
13. Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo. Wahiduzzaman M; Ota A; Karnan S; Hanamura I; Mizuno S; Kanasugi J; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Takami A; Hosokawa Y Cancer Lett; 2018 Oct; 433():117-130. PubMed ID: 29944906 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of small GTPase RalA regulates growth and arsenic-induced apoptosis in chronic myeloid leukemia (CML) cells. Zhu X; Li Y; Luo X; Fei J Cell Signal; 2012 Jun; 24(6):1134-40. PubMed ID: 22330069 [TBL] [Abstract][Full Text] [Related]
15. MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1. Zhou M; Zeng J; Wang X; Guo Q; Huang T; Shen H; Fu Y; Wang L; Jia J; Chen C J Transl Med; 2013 Oct; 11():265. PubMed ID: 24148180 [TBL] [Abstract][Full Text] [Related]
16. miR-153 sensitized the K562 cells to As2O3-induced apoptosis. Liu L; Chen R; Huang S; Wu Y; Li G; Zhang B; Liu Q; Yin D; Liang Y Med Oncol; 2012 Mar; 29(1):243-7. PubMed ID: 21267675 [TBL] [Abstract][Full Text] [Related]
17. VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia. Luo X; Feng M; Zhu X; Li Y; Fei J; Zhang Y Hematology; 2013 Nov; 18(6):334-40. PubMed ID: 24129092 [TBL] [Abstract][Full Text] [Related]
18. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes. Farhadi E; Zaker F; Safa M; Rezvani MR Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Cao Y; Yu SL; Wang Y; Guo GY; Ding Q; An RH Tumour Biol; 2011 Feb; 32(1):179-88. PubMed ID: 20857258 [TBL] [Abstract][Full Text] [Related]
20. Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment. Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G Cancer Lett; 2015 May; 360(2):245-56. PubMed ID: 25697481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]